Importantly, studies have also identified genetic lesions that define novel subtypes of ALL with distinct gene expression profiles, such as subtypes characterized by rearrangement of CRLF2 (14, 15), intrachromosomal amplification of chromosome 21 (16), focal deletions of ERG (17), and NOTCH1 (18). This evidence concerns the gene ERG and acute lymphoblastic leukemia.